Countering Covid-19 Vaccine Hesitancy Among Adolescents and Parents in India

This blog originally appeared in Times of India. Below is an excerpt.

Going by Ministry of Health’s statistics, India has successfully managed to administer first dose of vaccination to more than 100 crore eligible beneficiaries across states and union territories, which is far ahead of all developed nations including US and UK, who have covered 77.5 per cent and 78.2 per cent of its populations respectively.  This is a landmark achievement. 

But the Covid-19 vaccination drive for adolescents between 12 to 14 years, which started on March 16, 2022 is comparatively sluggish across the country, with a large section of parents being on the fence. 

What are the reasons for vaccine hesitancy in 12 to 14 years age group?

The disinclination towards the preventive jab for the younger age group has been in part, due to the infection trends witnessed during the first two waves, where it was perceived that the children, right from infants to adolescents were not as vulnerable to SARS CoV2 virus as the adult population, where the infections were severe and attributable deaths were much higher.

Another reason for hesitation among parents, who are the decision makers for this age-group has been little or no research data availability in the public arena to ascertain a correlation in terms of significant antibody development in children after vaccination. It is generally seen that parents are afraid of the after-effects of the vaccine as it is new and  fear that it is not tested enough, specifically in children.

Read the full blog here.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Delivering 270M+ COVID-19 vaccines at just $0.29 per dose: The Bangladesh experience

Bangladesh launched its COVID-19 vaccination program in February 2021 with the ambitious aim of reaching 80% of the population with two doses. The program used a phased approach, initially targeting priority groups, and expanding eligibility over time as supply ramped up. By June 2022, the country had achieved its goal—having delivered over 270 million COVID-19 … Read More

New evidence on the costing the delivery of COVID-19 vaccines in Mozambique and the Philippines

ThinkWell has released two new reports on the cost of delivering COVID-19 vaccines in Mozambique and the Philippines, aiming to support governments and address the knowledge gap on the cost of these vaccination programs. In partnership with the Universidade Eduardo Mondlane and Ateneo de Manila University, ThinkWell conducted retrospective, bottom-up costing studies, as well as … Read More